NEW

Siemens Healthineers to Acquire Varian

Siemens Healthineers AG and Varian Medical Systems Inc. have entered into an agreement, pursuant to which Siemens Healthineers shall acquire all shares of Varian for $177.50 per share in cash. This corresponds to a purchase price of approximately $16.4 billion....

MTMI Partners with Nautilus Medical Technologies

The Medical Technology Management Institute (MTMI), a division of The College of Health Care Professions, has announced a partnership with Nautilus Medical Technologies, developer of a cloud-based imaging sharing platform used by over a thousand health care providers...

Gillette Children’s Specialty Healthcare is the first U.S. hospital to image patients with EOSedge

EOS imaging, a provider of 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, has announced the first exams performed with EOSedge in the United States, at Gillette Children's Specialty Healthcare’s main campus...

Webinar on FDA’s Regulation of Face Masks and Surgical Masks during the COVID-19 Pandemic

On Tuesday, August 4, 12:00 p.m.-1:00 p.m. ET, the U.S. Food and Drug Administration (FDA) will host a webinar on the FDA’s regulation of face masks and surgical masks during the COVID-19 pandemic. This webinar will expand the scope of the respirator webinar series to...

HyperMed Imaging Announces Availability of New Product

HyperMed Imaging Inc. has announced that the company is now offering its new HyperView Imaging System for sale to customers in the United States.

The HyperView System is FDA cleared, and is a fast, handheld, battery operated, non-invasive and portable diagnostic imaging device that is used to assess tissue oxygenation without contacting the patient and without the need for injectable contrast. The system uses proprietary technology to capture color-coded images containing data that provides the clinician critical information such as oxyhemoglobin levels (Oxy), deoxyhemoglobin levels (Deoxy) and oxygen saturation (O2Sat) in superficial tissue. Such information may assist clinicians when determining if a patient has adequate blood perfusion to heal a wound or maintain healthy tissue. Understanding both arterial and venous sufficiency in the surface tissue may enable clinicians to make more informed decisions regarding when to intervene. The HyperView system also helps document perfusion levels before and after vascular interventional procedures such as: peripheral bypass, stent placement or balloon angioplasty.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *